Clinical Response to Rifaximin Amongst Irritable Bowel Syndrome (IBS) Patients at Tertiary Level Hospital in Nepal. J Patan Acad Health Sci 2024, 11 (1), 21-26. https://doi.org/10.3126/jpahs.v11i1.65652.